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Key questions
What is already known?
 ► Low-income and middle-income countries suffer 
the largest burden of morbidity and mortality due to 
non-communicable diseases (NCDs).
 ► Description of risk factors, blood pressure and blood 
glucose in rural Bangladesh by age, sex and wealth 
is needed to better plan and evaluate intervention 
initiatives.
What are the new findings?
 ► Three in four adults in rural Bangladesh report three 
or more NCD risk factors.
 ► One in three adults in rural Bangladesh have inter-
mediate hyperglycaemia or diabetes, and one in two 
adults have prehypertension or hypertension.
What do the new findings imply?
 ► The clear urgent need for prevention and treatment 
provides impetus for gender-sensitive, rural, com-
munity-based implementation of NCD policy and 
intervention programmes.
AbsTrACT
background Non-communicable diseases (NCDs) are 
increasing in low-income settings. We conducted a survey 
of risk factors, blood pressure and blood glucose in rural 
Bangladesh and assessed variations by age, sex and 
wealth.
Methods We surveyed a random sample of 12 280 
adults aged >30 years in 96 villages in rural Bangladesh. 
Fieldworkers measured blood glucose and conducted an 
insulin tolerance test with a repeat blood test 120 min 
post glucose ingestion. Blood pressure, anthropometric, 
socioeconomic, lifestyle and behavioural risk factors data 
were also collected. Data were analysed to describe the 
prevalence of diabetes, intermediate hyperglycaemia, 
hypertension and NCD risk factors by age, sex and 
wealth.
results Women had higher levels of overweight or obesity 
and lower levels of physical activity and fruit and vegetable 
consumption than men; 63% of men used tobacco 
compared with 41.3% of women. Overweight or obesity 
and abdominal obesity (waist to hip ratio) increased with 
socioeconomic status (least poor vs most poor: OR (95% 
CI) 3.21 (2.51 to 4.11) for men and 2.83 (2.28 to 3.52) for 
women). Tobacco use, passive smoke exposure and salt 
consumption fell with increasing socioeconomic status 
in both sexes. Clustering of risk factors showed more 
than 70% of men and women reported at least three 
risk factors. Women in the least poor group were 33% 
more likely to have three or more risk factors compared 
with women in the most poor group (1.33 (95% CI 1.17 
to 1.58)). The combined prevalence of impaired fasting 
glucose, impaired glucose tolerance and diabetes was 
26.1% among men and 34.9% among women, and 
increased with age. The prevalence of prehypertension 
and hypertension was 30.7% and 15.9% among men 
and 27.2% and 22.5% among women, with similar rising 
prevalence with age.
Conclusion NCD risk factors, hyperglycaemia and raised 
blood pressure are an immediate health threat in rural 
Bangladesh. Initiatives to improve detection, treatment and 
prevention strategies are needed.
InTroduCTIon
Approximately 80% of premature non-com-
municable disease (NCD) deaths occur in 
low-income and middle-income countries.1 
This burden is driven by early life exposures2–6 
and pandemics of overweight and obesity, 
tobacco use, air pollution, low levels of phys-
ical activity and high levels of salt intake, which 
disproportionately affect populations living 
in the world’s poorest countries.1 To address 
these burdens within resource-poor health 
systems, weak health information systems, 
highly unregulated private health sectors 
and ageing populations, it is first necessary to 
accurately measure and describe the burden 
of risk factors and disease.
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The prevalence of NCD risk factors is thought to be 
high in Bangladeshi adults, with more than one-third of 
the population aged 25 years or older reporting three 
or more common risk factors.7 The 2010 Bangladesh 
NCD Risk Factor Survey found high levels of NCD risk 
factors and reported that approximately 4% of adults 
aged 25 years or older had diabetes mellitus, although 
this was based only on self-reported diagnosis by a health 
professional.8 Among those aged over 35, the Bangladesh 
Demographic and Health Survey (BDHS) reported that 
24% had abnormal fasting glucose and 8% had diabetes 
according to fasting blood glucose results.9 Analysing the 
data from the BDHS, Akter et al10 found higher rates of 
diabetes according to age but no significant difference 
in male and female rates of diabetes or impaired fasting 
glucose (IFG) levels. While there was a significant differ-
ence between the poorest and richest households in 
diabetic status rates (6.4% of the poorest households and 
19.2% richest households), the difference was consider-
ably lower for IFG levels (19.7% and 23.5%, respectively). 
Other studies report varying levels of hyperglycaemia 
(including IFG, impaired glucose tolerance (IGT) and/
or diabetes), ranging from 9% to 30% depending on 
study setting, level of urbanisation, age of study popula-
tion, methods of blood glucose assessment and timing 
of study.11–18 Furthermore, a recent review by Rahman et 
al19 describes a threefold to fourfold increase in diabetes 
prevalence between 1992 and 2015, with levels expected 
to reach 23.6% in men and 33.5% in women by 2030 
That is three to four times greater than the 2016 age-stan-
dardised global prevalence estimate of 8.5% for adults.20
The Bangladesh NCD Risk Factor Survey also found 
that one-third of adults self-reported a medical diagnosis 
of hypertension,8 although study estimates of hyperten-
sion prevalence range from 11% to 40%, with increases 
generally corresponding with more urban locations, older 
study populations and increasing socioeconomic status, 
recency of survey and individual comorbidities such as 
diabetes.7 21–27 Analyses of the 2011 BDHS data report the 
prevalence of hypertension to be higher among women 
than men.28 Rahman et al19 describe an increase in the 
prevalence of hypertension among men and women of 
approximately 50% and 85%, respectively, between 1992 
and 2015.
Socioeconomic inequalities in hyperglycaemia, raised 
blood pressure and NCD risk factors have been described, 
with a high burden of NCDs observed among low-wealth 
quintile populations in rural areas and wealthier popu-
lations in urban areas.29 Further, evidence suggests that 
increasing levels of wealth and educational attainment 
are associated with increased likelihood of having hyper-
tension and hyperglycaemia,26 28 30 and individuals with 
comorbid diabetes and hypertension from low socio-
economic groups are less likely to be diagnosed, receive 
treatment or control their blood pressure.25
This paper presents an epidemiological survey 
conducted by the Diabetic Association of Bangladesh 
and University College London. As part of a cluster 
randomised controlled trial in a rural Bangladeshi 
population,31 we conducted a large, community-based, 
cross-sectional survey of NCD risk factors, blood glucose 
and blood pressure to describe the prevalence and vari-
ance by age, sex and socioeconomic status, and to discuss 
awareness, treatment and control of diabetes and hyper-
tension in this setting.
MeTHods
The study included 96 villages in four rural upazilas—
Nagarkanda, Boalmari, Saltha and Madhukhali—in 
Faridpur District, located south of Dhaka. Faridpur 
District has a population of over 1.7 million people in 
an area of just over 2000 square kilometres and is situ-
ated on the banks of Padma River. The district has a 
mainly agricultural-based economy, with the main crops 
being jute and rice. As in the rest of Bangladesh, primary 
care is provided at Union Health and Family Welfare 
Centres and at community clinics. Inpatient and outpa-
tient services are provided at subdistrict (upazila) health 
complexes and hospitals, and tertiary care is provided at 
district hospitals and medical college hospitals.32 Private 
service providers are also present in the area, including 
a Diabetic Association of Bangladesh Medical College 
in Faridpur town. Nevertheless, access to facilities and 
trained healthcare providers, short supplies of medicines 
and low responsiveness of services remain as challenges 
in Faridpur District.
The study population includes male and non-pregnant 
female permanent residents of 96 villages aged 30 years 
or more. A person is considered a permanent resident of 
a village if they normally live in that village. A sampling 
frame of all eligible participants was developed between 
October and December 2015 by listing all households 
and their eligible members within each of the study 
villages. A sample of 143 adults aged 30 years and above 
was selected from this sampling frame using multistage 
random sampling. In the first stage, 143 households with 
at least one eligible adult resident were selected using 
probability proportional to size sampling. In the next 
stage, a single eligible adult was selected from each of the 
143 households for inclusion in the survey using simple 
random sampling. The sample size was determined by 
trial requirements described elsewhere.31 In terms of 
epidemiological analysis, the total sample size allows 
estimation of the true population prevalence of inter-
mediate hyperglycaemia and diabetes mellitus with 99% 
confidence and an accuracy of between 1% and 2%.
Data were collected by 16 teams of fieldworkers 
that comprised one male and one female with at least 
secondary education who were recruited locally and 
selected through a written assessment and interview. 
All fieldworkers underwent 12 days of physician-led 
training on the survey methods and how to take physical 
measurements, followed by 2 weeks of supervised field 
practice and daily debriefs in villages in Faridpur that 
were not included in the study. This was followed by 3 
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Table 1 Glycaemic definitions and diagnostic criteria
Definition Diagnostic criteria
Normoglycaemia Fasting plasma glucose <6.1 mmol/L
Intermediate hyperglycaemia 
  Impaired fasting glucose Fasting plasma glucose ≥6.1 mmol/L to <7.0 mmol/L AND 2-hour postingestion of 75 g 
glucose load plasma glucose <7.8 mmol/L.
  Impaired glucose tolerance Fasting plasma glucose<7.0 mmol/L AND 2-hour postingestion of 75 g glucose load 
plasma glucose ≥7.8 mmol/L to <11.1 mmol/L.
Type 2 diabetes mellitus
Fasting plasma glucose ≥7.0 mmol/L OR* 2-hour postingestion of 75 g glucose load 
plasma glucose >11.1 mmol/L.
Adapted from WHO 200659.
*Diabetes cannot be excluded without 2-hour post oral glucose load test.
days of refresher training before the start of the survey 
on 23 January 2016. Data collectors were supervised by 
four field supervisors with experience in survey methods. 
Each supervisor was responsible for four data collection 
teams, spending half a day observing and verifying data 
within each team at least every 2 days. Within each village, 
teams were aided by a village assistant, usually a young 
man, who received a daily payment to coordinate study 
participants and assist data collectors in their duties.
All sampled individuals in a single cluster were 
informed of the anthropometric, blood glucose and 
blood pressure measurement requirements of the study 
and, following consent, were requested to attend a local 
centre on the morning of a specified day following an 
overnight fast. Centres were established by the field team 
for the purposes of the study and were at a central, conve-
nient location in the village. Physical measurements were 
recorded by data collection teams at the testing centres. 
Blood glucose was measured using the OneTouch Ultra 
Glucometer (LifeScan, Milpitas, California) in whole 
blood obtained by finger prick from capillaries in the 
middle or ring finger after an overnight fast. All individ-
uals then received a 75 g glucose load dissolved in 250 
mL of water. A 2-hour postprandial repeat capillary blood 
test was then conducted to determine glucose tolerance 
status and differentiate between individuals with interme-
diate hyperglycaemia and those with diabetes according 
to the WHO criteria (table 1).
Sitting blood pressure was measured using the Omron 
HBP-1100 Professional Blood Pressure Monitor (Kyoto, 
Japan). Two measurements were taken at approximately 
5 min intervals and the respondent’s blood pressure 
obtained by taking the average of these measurements. 
Measurements of height, weight, and waist and hip girth 
were taken with light clothes and without shoes. The 
weighing tools were calibrated daily by known weight. 
For height, the subject stood in erect posture vertically 
touching the occiput, back, hip and heels on a wall while 
gazing horizontally in front and keeping the tragus and 
lateral orbital margin in the same horizontal plane. Waist 
girth was measured by placing a plastic tape horizon-
tally mid-way between the 12th rib and the iliac crest on 
the mid-axillary line. Similarly, hip circumference was 
measured by taking the extreme end posteriorly and 
the symphysis pubis anteriorly. Physical measures were 
recorded onto specifically designed paper forms and 
later entered into Samsung Galaxy Grand Prime large 
screen smartphones using ODK Collect with logic and 
range-check controls.33
We collected detailed information on the sociodemo-
graphic characteristics of all consenting individuals using 
a structured survey instrument adapted from the 2010 
Bengali WHO Stepwise tool8 34 and the 2011 BDHS,9 
which was designed to measure the background demo-
graphic and socioeconomic characteristics, lifestyle and 
behavioural risk factors among study participants. Ques-
tionnaire data were gathered using an ODK form on the 
mobile phone and linked to the physical measurement 
data using unique personal identification numbers. 
Collection of questionnaire data took place at the respon-
dent’s home before or after the physical measurements or 
at the time of physical measurement in the testing centre. 
Data quality control measures were implemented within 
the ODK system (eg, range and consistency checks) and 
through repeat measures by supervisors on a random 
basis and where outlier data were recorded. Data were 
uploaded from mobile phones to the supervisors’ laptop 
every 2 days and then transferred to a central database 
at the Faridpur field office for further data checks and 
quality control before being transferred on a weekly basis 
to the main project office in Dhaka, where final data 
checking was implemented, with any data queries being 
referred back to the field for verification and remeasure-
ment if necessary.
Analyses were restricted to those who provide at least 
partial data in both the physical measurement survey 
and the interview survey. Descriptive analysis summarised 
study population characteristics (sex, 10-year age cate-
gories, marital status, education, literacy, occupation, 
household wealth and religion), the prevalence of 
disease indicators (IFG, IGT, diabetes, prehypertension 
and hypertension), and risk factors for overweight and 
obesity (body mass index (BMI) ≥23 using cut-off values 
for South Asian populations),35 abdominal obesity (waist 
to hip ratio >0.85 for women and ≥0.9 for men),36 tobacco 
use, exposure to passive tobacco smoke, inadequate fruit 
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and vegetable intake (defined as less than five servings 
per day), salt intake (defined as additional salt added 
to every meal after it has been cooked), and inadequate 
physical activity (defined as less than 150 min of physical 
activity per week). Clustering of risk factors was defined 
as three or more risk factors reported in the same indi-
vidual, as has been used in previous studies.7
Households were categorised into five socioeconomic 
quintiles using a wealth index derived from principal 
components analysis of the household’s ownership of 
assets, housing characteristics and sanitation facilities. 
Hyperglycaemia (IFG, IGT and diabetes) was based on 
blood glucose concentration categorised according to 
the WHO diagnostic criteria (table 1) or self-reported 
diagnosis of diabetes by a medical professional. Prehyper-
tension was defined as systolic blood pressure ≥120 mm 
Hg and <140 mm Hg or diastolic blood pressure ≥80 mm 
Hg and <90 mm Hg. Hypertension was defined as systolic 
blood pressure ≥140 mm Hg or diastolic blood pressure 
≥90 mm Hg, or self-reported diagnosis of hypertension by 
a medical professional or self-reported current treatment 
with antihypertensive medication. Risk factor and disease 
outcomes were presented by age and wealth quintile and 
stratified by sex. Associations between age and wealth 
quintile and risk factors and disease were assessed using 
logistic regression adjusted for potential confounding 
factors of education, occupation, literacy, marital status, 
and either wealth or age group, respectively. Awareness 
of diabetic and hypertensive status was determined by the 
proportion of individuals meeting the diagnostic criteria 
who reported a prior knowledge of their disease status. 
Treatment for diabetes and hypertension was based 
on ever receiving treatment or advice for diabetes or 
hypertension from a medical professional among those 
who had a previous medical diagnosis of either disease. 
Control was defined as individuals with diabetes or hyper-
tension who had prior knowledge of their disease status 
and did not meet the objective diagnostic criteria in our 
survey measures of blood glucose or blood pressure. All 
analyses were carried out in Stata V.13 and adjusted for 
the clustered and stratified survey design and weighted 
to account for the unequal probability of selection of a 
fixed number of individuals within villages of unequal 
size using the ‘svy’ command in Stata.
Participation in the surveys was voluntary and informed 
consent was obtained from all participants before any 
data were collected. No reimbursements or incentives 
were given to participants. Individuals identified with 
raised blood glucose or raised blood pressure indicating 
diabetes or hypertension, respectively, were advised to 
visit qualified health professionals for further testing and 
care advice.
resulTs
response rate and study population
Using the sampling frame we developed a target sample 
list of 13 684 individuals. Note that this number is slightly 
lower than the expected target of 143 individuals in each 
of the 96 villages (13 728 individuals) as 2 villages only 
had 128 and 114 eligible individuals living in separate 
households, respectively.
Data were collected from a total of 12 280 individuals 
(5669, 46.2% male; 6471, 52.7% female) out of a target 
of 13 684 between January and March 2016, repre-
senting an overall response rate of 89.5%. A total of 12 
047 (87.8%) individuals (5615, 46.6% male; 6432, 53.4% 
female) provided at least partial data in the physical 
measurement survey and the interview survey and are 
included in the following analysis. Using sampling frame 
data, it was possible to explore age bias in response rates. 
Male non-responders were younger (mean age 45.4 years 
(SD 13.0)) than male responders (48.9 years (SD 13.8)); 
p<0.001). Conversely, female non-responders were 
slightly older (49.3 (SD 17.8)) compared with female 
responders (46.6 (SD 13.6); p<0.001).
Study population characteristics are presented in 
table 2 and show that approximately 90% of the popu-
lation were Muslim. Overall, the population had low 
levels of education and literacy, although there were 
notable differences between men and women and by age 
group. Two-thirds of men worked in manual occupations, 
whereas 94% of women had no paid employment. The 
proportion of women who were married at the time of 
the survey decreased considerably with increasing age.
risk factors
Table 3 and figure 1 present the level of NCD risk 
factors and risk factor clustering by wealth quintile and 
sex. Overall, compared with men, women had higher 
levels of overweight or obesity and lower levels of phys-
ical activity and fruit and vegetable consumption. Men 
in all wealth groups had higher levels of tobacco use, 
with 63.3% of all men currently using tobacco compared 
with 41.3% of women. Method of tobacco use differed 
substantially between sexes, with 87% of men smoking 
tobacco compared with just 1% of women, who generally 
consumed tobacco orally or nasally.
Among men and women, there was a clear increasing 
trend of overweight or obesity and abdominal obesity 
(waist to hip ratio) with increasing socioeconomic 
status—the odds being approximately two to three times 
higher in the highest socioeconomic group compared 
with the lowest in both men and women. An apparent 
decreasing trend in tobacco use, passive smoke expo-
sure and salt consumption was observed with increasing 
socioeconomic status in men and women, although 
prevalence remained high in all groups. Fruit and vege-
table consumption and physical activity were low and 
were more evenly distributed across all socioeconomic 
groups in both men and women. However, men in the 
least poor group were approximately one-third less likely 
to be physically inactive compared with men in the most 
poor group. Clustering of risk factors was high in both 
sexes, with more than 70% of men and women reporting 
at least three risk factors. While there was no evidence of 
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Figure 1 NCD risk factor prevalence by wealth quintile, age group and sex among adults aged 30 years and older in rural 
Faridpur. NCD, non-communicabledisease; WHR, waist to hip ratio.
the prevalence of risk factor clustering differing by socio-
economic status among men, an apparent increasing 
trend with increasing wealth appeared among women.
Table 3 and figure 1 also show the prevalence of NCD 
risk factors and risk factor clustering by age group and 
sex. Among men and women we see a decreasing trend 
in overweight and obesity with increasing age, although 
there is evidence of increasing abdominal obesity in 
both sexes with increasing age. Current tobacco use 
was strongly associated with age group, with the odds 
of tobacco use being 2.5 times and 4.5 times higher 
among older (70+ years) men and women, respectively, 
compared with men and women aged 30–39. Conversely, 
although one-third of men and women were exposed to 
passive tobacco smoke, the odds of exposure decreased 
with increasing age.
High prevalence of inadequate fruit and vegetable 
intake (less than five portions per day) persists across all 
ages and appears to increase with age group, particularly 
among women. Similarly, salt consumption was high at all 
ages. The pattern of low levels of physical activity by age 
group varied considerably between men and women. For 
men, three-quarters of men aged 30–39 years engaged 
in at least 150 min of physical activity per week, and 
this increased to more than 80% by age 50–60 before 
declining in older age groups. A similar proportion of 
younger women engaged in adequate physical activity as 
their male counterparts, but this decreased sooner and 
to a greater extent among women as they got older, with 
only around 30% of women aged 70 years or more main-
taining adequate levels of physical activity. Consequently, 
there was a high prevalence of clustering of risk factors 
among men and women which increased with age, but 
women reached and maintained a high prevalence, with 
approximately three in four women being exposed to at 
least three risk factors by the age of 40–49 years—higher 
than men in any age group.
IFG, IGT and diabetes
The overall prevalence of intermediate hyperglycaemia 
and diabetes was 17.2% and 8.9% among men and 
23.4% and 11.5% among women, respectively (table 4; 
figure 2). There is no clear evidence of an association 
between IFG and IGT with wealth quintile among men or 
women. However the odds of diabetes was approximately 
50% higher in men in the least poor group compared 
with men in the poorest group. The relationship between 
diabetes and wealth appears to be stronger among 
women, with those in the lowest wealth quintile having 
significantly lower odds than most other wealth groups.
With regard to age group, there is evidence of 
increasing hyperglycaemia with increasing age among 
men such that the prevalence rose from approximately 
one in five men aged 30–39 years to more than one in 
three men aged 60 years and above. A similar trend is 
observed for women, although at a higher level, with 
45% of women aged 70 years or above having IFG, IGT 
or diabetes (table 4; figure 2).
raised blood pressure
Almost half of men and women aged 30 years and above 
in our study sample were categorised as prehypertensive 
or hypertensive (table 4; figure 2). There is no strong 
evidence of an association between these hypertensive 
measures and wealth quintile among men. There is no 
evidence of an association between wealth quintile and 
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Figure 2 Impaired fasting glucose (IFG), impaired glucose tolerance (IGT), diabetes, prehypertension and hypertension 
prevalence by wealth quintile, age group and sex among adults aged 30 years and older in rural Faridpur.
prehypertension among women, but an increasing trend 
in hypertension with increasing wealth is observed, with 
women in the two least poor quintiles being 43% and 
87% more likely to have hypertension compared with 
women in the poorest group, respectively.
Age is much more clearly associated with hypertension 
among men and women, although there is little evidence 
of effect of age on prehypertension (table 4; figure 2). 
Although starting from different baseline prevalences in 
the youngest age groups, the prevalence of hypertension 
rose higher and at younger ages among women than men 
such that there was approximately a doubling of odds of 
hypertension among women between 30–39 years and 
40–49 years, with significant but smaller incremental 
increases for every subsequent age group.
diabetes and hypertension status awareness, treatment and 
control
Among the 1225 individuals identified to be diabetic, 
only 307 individuals (24.6%) were already aware of their 
diabetic status. Of these 307, 95% (n=292) had been 
informed of their status by a trained medical profes-
sional. Women with diabetes were 37% less likely than 
men to know that they were diabetic (OR 0.63 (95% 
CI 0.48 to 0.81)). Of those who had been informed by 
a trained medical professional prior to our survey, 252 
(86.1%) reported ever receiving medical treatment or 
advice. There was no evidence of a difference between 
women and men in the odds of receiving treatment (OR 
0.79 (95% CI 0.41 to 1.55). Of the 307 individuals with 
diabetes who reported prior awareness of their diabetic 
status, 306 underwent blood glucose testing in our survey 
and 245 (80.2%) of these had fasting plasma glucose 
≥7 mmol/L or 2-hour post glucose load plasma glucose 
≥11.1 mmol/L, indicating suboptimal control of the 
condition (figure 3A).
Of the 2367 individuals identified with hypertension 
through our measurements, 1283 (54.6%) reported 
that they aware that they had hypertension prior to our 
survey, with 967 (75.8%) of these individuals having 
previously been informed by a trained medical profes-
sional. In contrast to diabetes, women with hyperten-
sion were more likely to be aware of their status than 
men (OR 1.74 (95% CI 1.44 to 2.09)). Of those who had 
been informed of their hypertensive status by a trained 
medical professional prior to ours, 87.3% reported ever 
receiving medical treatment or advice, with no apparent 
differences between women and men, 1.10 (95% CI 0.74 
to 1.64). Of the 1283 individuals with hypertension who 
reported prior awareness of their hypertensive state, 
61.2% (n=796) had raised blood pressure (systolic blood 
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Figure 3 Diabetes (A) and hypertension (B) awareness and control among our study population identified with these 
conditions in rural Faridpur.
pressure ≥140 mm Hg or diastolic blood pressure ≥90 
mm Hg) at the time of our survey (figure 3B).
dIsCussIon
Between a quarter and one-third of adults aged 30 years 
or older in rural Bangladesh have IFG, IGT or diabetes, 
and approximately half of all adults have raised blood 
pressure that meets the standard definition of prehyper-
tension or hypertension. Despite these high burdens of 
raised blood sugar and blood pressure, three-quarters of 
individuals with diabetes and almost half of the individuals 
with hypertension were unaware of their status prior to 
our survey. Women are more affected than men in terms 
of raised blood sugar and raised blood pressure, as well 
as in terms of most NCD risk factors. Nevertheless, a high 
prevalence of common NCD risk factors persists across 
age, wealth and sex groups, with almost three-quarters 
of the adult population aged 30 years or older reporting 
three or more risk factors. This clustering of factors 
raises risk by more than a summation of findings,7 so the 
observed burden of dysglycaemia and raised blood pres-
sure is likely to increase in the immediate future. Overall, 
these data describe a huge unmet need for prevention, 
care-seeking and control of NCDs in rural Bangladesh, 
with likely consequences on the individuals affected and 
the wider household, community and economic environ-
ment in which these individuals live.37
Our large, population-based sample size, randomly 
selected from a contemporary and purpose-made 
sampling frame, rigorous fieldworker training, and data 
quality control measures are major strengths of our study. 
Direct measurement of fasting and 2-hour post glucose 
load blood sugar levels using capillary whole blood was 
logistically more complicated than random blood glucose 
or fasting-only measures as is commonly used in commu-
nity-based surveys in low-income settings, but increases 
confidence in our population estimates of IFG, IGT 
and diabetes prevalence. Nevertheless, despite having 
been acceptable for epidemiological studies,38 39 capil-
lary blood glucose levels can overestimate blood sugar 
compared with venous samples, and so our prevalence 
estimates may be higher than would be achieved using 
more stringent clinical methods. Prevalence estimates 
may also have been affected by including individuals 
with self-reported prior medical diagnosis of diabetes 
and hypertension in the numerator. The validity of these 
self-reports or the diagnostic criteria used in earlier diag-
noses is unknown.
Given the time commitment and inconvenience asked 
from respondents, our response rate of almost 90% is 
exceptionally good. Nevertheless, we did observe some 
potential response bias in terms of age, with male non-re-
sponders being younger and female non-responders 
being older than their responding counterparts. This 
likely reflects the fact that younger men were less able 
to commit the time required for our survey due to work 
commitments, whereas older women may simply have 
been less inclined to participate. The consequence of 
these potential response biases is that our findings may 
under-represent the younger male population and so 
potentially overestimate the overall burden of risk factors 
and disease associated with increasing age. Conversely, 
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our data may under-represent older women and so under-
estimate the overall burden given that we see increasing 
prevalence of risk factors and disease with age group.
The cross-sectional design and contemporary measure-
ment of socioeconomic status, age and NCD risk factors 
must also influence our interpretation of observed asso-
ciations and limit inferences of cause and effect. Further-
more, although homogeneity in rural Bangladeshi 
populations has been noted by others,40 extrapolation 
of our findings to other rural areas must be done with 
caution, and our findings are likely to be different from 
those from an urban or mixed population. Finally, our 
large sample size, based on trial assumptions of effect size, 
prevalence and intracluster correlation, may increase the 
risk of type 1 one errors. As such, we have taken care to 
present and interpret measures of associations in terms 
of their magnitude and trends, with emphasis on public 
health significance rather than statistical significance.
High BMI is an important risk factor for NCDs, and 
halting its increasing prevalence is included in the WHO 
Global Action Plan for the prevention and control of 
NCDs.41 Overweight and obesity have been shown to 
increase the risk of NCDs, and abdominal obesity in 
particular is associated with increased risk of meta-
bolic syndrome and diabetes.42–45 The high burdens of 
overweight and obesity among younger age groups are 
alarming and, given the majority of risk factors increase 
with age, set an unhealthy basis on which further risk 
may be added. Being underweight is also associated with 
increased risk of morbidity and mortality, a so-called 
J-shaped association.46 In our data we found that 25% of 
underweight individuals (BMI<18.5) had intermediate 
hyperglycaemia or diabetes, and around 38% had raised 
blood pressure (data not shown). Public health and 
policy approaches to NCD prevention must therefore 
recognise this complex relationship between risk factors 
and disease, rising to the challenge of tailoring dietary 
advice appropriately for heterogeneous at-risk popula-
tions, especially in settings where household food insecu-
rity remains an issue.47
The WHO recommends intake of a minimum of 400 
g of fruits and vegetables per day, citing evidence that 
this can help to reduce the risk of obesity, diabetes and 
cardiovascular diseases.48 To promote this behaviour, 400 
g of fruit and vegetables has frequently been translated 
into five portions of fruits or vegetables per day. Based on 
this cut-off, our data show very high levels of inadequate 
fruit and vegetable consumption across all ages and 
wealth groups and men and women, although there is an 
apparent trend in increasing inadequate intake with age. 
It is known that an individual’s likelihood of achieving 
‘five-a-day’ is affected by many individual-level and house-
hold-level factors, one of the most important of which 
is socioeconomic status.49 Indeed, our analysis by wealth 
quintile does indicate an increasing trend in fruit and 
vegetable consumption with increasing wealth, although 
this is not statistically significant and, even in the least 
poor group, only around 27% of men and 16% of women 
achieve the recommended daily intake. In interpreting 
the data on fruit and vegetable consumption, however, it 
is important to note that respondents generally found the 
WHO STEPS question on consumption on a ‘typical day’ 
in a ‘typical week’ difficult to conceptualise, reflecting 
temporal variations in fruit and vegetable availability and 
affordability within this population.
High dietary salt intake is an important risk factor for 
NCDs, especially hypertension. It has been identified 
as an indicator of the NCD Global Monitoring Frame-
work, which targets a 30% relative reduction of dietary 
salt between 2010 and 2025. Progress towards this target 
requires quantification of salt intake. Few studies have 
attempted to do this in Bangladesh, and the quality of 
estimates is limited by selection bias, small sample sizes or 
reliance on production and sales data. Nevertheless, the 
available data suggest an average salt intake of between 15 
g/day and 21 g/day,50–52 three to four times higher than 
the recommended 5 g daily limit.48 We did not attempt to 
quantify salt intake in our study but did ask respondents 
whether they added salt to their food after it was cooked 
and how often, with approximately 50% of all age and 
wealth groups reporting that they add salt to every meal. 
The addition of salt to food ‘at the table’ is considered 
a primary target for salt reduction,50 and campaigns are 
under way in Bangladesh. The activities undertaken by 
the National Heart Foundation of Bangladesh for salt 
reduction include raising awareness through organising 
seminars in different areas of the country, holding consul-
tative meetings with stakeholders including the food and 
beverage industry, as well as generating evidence through 
surveys and studies, for example.53 Policy support that 
stresses the importance of salt reduction and addresses 
salt content of processed foods by formulating appro-
priate laws and regulations, setting goals, and supporting 
monitoring and evaluation is lacking.53
There is good evidence that regular physical activity 
of at least 150 min of moderate-intensity to vigorous-in-
tensity per week reduces rates of all-cause mortality and 
a number of NCDs.54 Even relatively small amounts of 
physical activity such as walking are shown to provide 
health benefits among high-risk adults, including those 
with hypertension, diabetes and/or high BMI.55 Our 
data show that between one-fifth and a third of men and 
women do not achieve these levels of physical activity. 
These estimates are slightly lower than the estimates of 
35%–38% physical inactivity among Bangladeshi adults 
aged 25 years and older based on the 2010 WHO STEPS 
survey.7 56 These differences may possibly be explained by 
the exclusively rural population of our study compared 
with the mixed (rural and urban) STEPS survey. Women 
are at greater risk of physical inactivity overall and become 
increasingly inactive at younger ages than men. This likely 
reflects the distinct gender roles and cultural norms of 
physical activity within this rural context. Among women, 
the levels of physical activity decrease significantly from 
age 50 years and above, while no significant difference is 
observed among men until age 70 and above. Evidence of 
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association with wealth group is not particularly strong, 
although it does appear that physical activity levels are 
better among the least poor men and women relative to 
the poorest group.
Our data on tobacco use support previous estimates in 
Bangladesh57 and reveal exceptionally high use among 
men and women, although mode of use differs between 
sexes, with more women chewing tobacco or using snuff 
than men (figure 2). Correspondingly, passive exposure 
to tobacco smoke is high, although it decreases with 
age—this reflects cultural norms of not smoking in front 
of one’s elder. A decreasing trend in tobacco use with 
wealth is apparent, the reasons for which are unclear. 
The decreasing trend with wealth, also observed with 
passive smoke exposure, salt consumption and clustering 
of risk factors, may reflect greater awareness, motivation 
and opportunity to avoid risk in wealthier individuals, 
although further research is required to explore this. In 
2013, the National Assembly of Bangladesh passed the 
Tobacco Control Law Amendment Bill, which was consid-
ered a major step forward in tobacco control measures as 
it included smokeless tobacco products and the expan-
sion of public places that are to be smoke-free. Further 
community-based behaviour change and smoking cessa-
tion initiatives are required to complement such govern-
mental initiatives.
Our estimates of intermediate hyperglycaemia, 
diabetes and raised blood pressure add to the range of 
estimates for Bangladesh, being comparable, although 
slightly higher than the BDHS diabetes estimates9 and 
the Bangladesh NCD Risk Factor Survey estimates of 
hypertension.7 21–27 Our higher estimates may be an 
artefact of methodological differences or may repre-
sent the increasing burden of disease in this context. 
Within the context of high prevalence of disease, aware-
ness and control of one’s own diabetic and hypertensive 
state remain low and are comparable with that reported 
for hypertension elsewhere in Bangladesh and other 
South Asian populations.58 It is not surprising that the 
2010 Bangladesh NCD Risk Factor Survey found only 
4% of adults aged 25 years or older with a self-reported 
diagnosis of diabetes by a health professional.8 Differ-
ences observed in awareness of hypertension between 
the sexes may reflect greater rates of detection among 
women during antenatal care or other care-seeking 
during pregnancy and childbirth which, depending on 
the availability and quality of services, may also offer 
opportunities for greater detection of diabetes among 
women. Increasing detection among men and women 
however remains a challenge that requires interventions 
that raise overall awareness of the risk factors, signs and 
symptoms of both conditions, inform populations about 
opportunities and benefits of monitoring one’s own 
health, and address limited opportunities for testing 
within public-sector and private-sector health providers 
located in rural areas.
ConClusIon
NCD risk factors, hyperglycaemia and raised blood pres-
sure are an immediate and often unrecognised health 
threat in rural Bangladesh. There is an urgent need for 
gender-sensitive health service and community-based 
initiatives to improve detection and treatment strategies 
while also preventing the growing disease burden.
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